Uromodulin blood test for sepsis-related kidney injury
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether a blood protein called uromodulin can help predict how well people with sepsis and acute kidney injury will do. Sepsis is a serious infection, and acute kidney injury is a sudden drop in kidney function. The results may help doctors better understand and manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have sepsis (a severe infection that causes your body to respond incorrectly) and be in the intensive care unit (ICU).
- You must have acute kidney injury (a sudden drop in kidney function) as defined by standard criteria.
- You must be able to provide consent, or have a family member or legal guardian who can do it for you.
- You cannot have end-stage kidney disease, a kidney transplant, or other kidney conditions that might affect the test (such as polycystic kidney disease, a single kidney, heart failure, or pregnancy).
- You cannot be on certain medications that suppress the immune system, such as high-dose steroids or chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
This study tests whether two substances in urine (TIMP2 and IGFBP7) can help doctors predict which patients with sepsis-related kidney problems will get worse. If these markers work, doctors could identify high-risk patients earlier and treat them more aggressively.
This study is testing a combination of methods, including a bedside ultrasound of your kidneys, to help diagnose acute kidney injury that happens as a complication of sepsis. The goal is to find out if this approach can detect kidney problems early so doctors can treat them sooner.
This trial looks at acute kidney injury that can happen during sepsis (a serious body-wide infection or suspected infection). It may help improve how doctors detect and manage kidney problems early, especially in intensive care or around major surgery.
This study looks at how the immune system responds in patients who develop sepsis after surgery and how it relates to kidney injury. It aims to help improve care for conditions like this.
This trial tests if a new drug, AZD4144, can help people with sepsis-related acute kidney injury in the ICU. It aims to see if the drug can improve kidney recovery and reduce complications.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.